Jia Ye

Beijing, 100176, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A highly selective 1,2-dihydroquinoxaline derivative as a potent PRMT5-MTA complex inhibitor.

A highly selective 1,2-dihydroquinoxaline derivative as a potent PRMT5-MTA complex inhibitor.

Journal: Bioorganic & medicinal chemistry

Published: April 22, 2026

Anti-arthritic effect of spirocyclopiperazinium bromide DXL-A-24 in CFA-induced arthritic rats and its mechanism.

Anti-arthritic effect of spirocyclopiperazinium bromide DXL-A-24 in CFA-induced arthritic rats and its mechanism.

Journal: European journal of pharmacology

Published: March 05, 2024

Design, synthesis and evaluation of quinazoline derivatives as Gαq/11 proteins inhibitors against uveal melanoma.

Design, synthesis and evaluation of quinazoline derivatives as Gαq/11 proteins inhibitors against uveal melanoma.

Journal: Bioorganic chemistry

Published: October 16, 2023

Effect and underlying mechanisms of spirocyclopiperazinium salt compound DXL-A-24 in rats following spinal nerve ligation.

Effect and underlying mechanisms of spirocyclopiperazinium salt compound DXL-A-24 in rats following spinal nerve ligation.

Journal: Brain research

Published: September 30, 2022

Effect of spirocyclopiperazinium salt compound LXM-15 on spinal nerve injury in rats.

Effect of spirocyclopiperazinium salt compound LXM-15 on spinal nerve injury in rats.

Journal: European journal of pain (London, England)

Published: April 17, 2021

Anti-arthritic Effect of the Spirocyclopiperazinium Salt Compound LXM-15 in Rats and Its Underlying Mechanism.

Anti-arthritic Effect of the Spirocyclopiperazinium Salt Compound LXM-15 in Rats and Its Underlying Mechanism.

Journal: Inflammation

Published: January 18, 2020

Antinociceptive Effect of Spirocyclopiperazinium Salt Compound DXL-A-24 and the Underlying Mechanism.

Antinociceptive Effect of Spirocyclopiperazinium Salt Compound DXL-A-24 and the Underlying Mechanism.

Journal: Neurochemical research

Published: May 26, 2019

Buyang Huanwu Decoction ameliorates ischemic stroke by modulating multiple targets with multiple components: In vitro evidences.

Buyang Huanwu Decoction ameliorates ischemic stroke by modulating multiple targets with multiple components: In vitro evidences.

Journal: Chinese journal of natural medicines

Published: September 24, 2017

Antinociception of the spirocyclopiperazinium salt compound LXM-15 via activating α7 nAChR and M4 mAChR and inhibiting CaMKIIα/cAMP/CREB/CGRP signalling pathway in mice.

Antinociception of the spirocyclopiperazinium salt compound LXM-15 via activating α7 nAChR and M4 mAChR and inhibiting CaMKIIα/cAMP/CREB/CGRP signalling pathway in mice.

Journal: Regulatory toxicology and pharmacology : RTP

Published: August 10, 2017

Anti-inflammatory effect and mechanism of the spirocyclopiperazinium salt compound LXM-15 in rats and mice.

Anti-inflammatory effect and mechanism of the spirocyclopiperazinium salt compound LXM-15 in rats and mice.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: May 10, 2017

Antinociception of spirocyclopiperazinium salt compound LXM-10-M targeting α7 nicotinic receptor and M4 muscarinic receptor and inhibiting CaMKIIα/CREB/CGRP signaling pathway in mice.

Antinociception of spirocyclopiperazinium salt compound LXM-10-M targeting α7 nicotinic receptor and M4 muscarinic receptor and inhibiting CaMKIIα/CREB/CGRP signaling pathway in mice.

Journal: European journal of pharmacology

Published: June 01, 2015

Iminosugar derivative WGN-26 suppresses acute allograft rejection via inhibiting the IFN-γ/p-STAT1/T-bet signaling pathway.

Iminosugar derivative WGN-26 suppresses acute allograft rejection via inhibiting the IFN-γ/p-STAT1/T-bet signaling pathway.

Journal: International immunopharmacology

Published: July 12, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026